RHY 3.23% 6.0¢ rhythm biosciences limited

To your point @goedy there is a single part-government-funded...

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    To your point @goedy there is a single part-government-funded DNA test 'Cologuard' in the US, however, it's a POO test costing around $500. Insurance companies like it because it's cheaper than a colonoscopy.

    The various DNA PLASMA (blood) tests in development to date are not good at detecting advanced adenomas (pre-cancerous polyps), they only achieve around 20% sensitivity. The whole point of population screening is early detection.

    Rhythm's Colostat on the other hand achieves 87.5% sensitivity for Stage 1, so we can assume at least 60% for advanced adenomas. It offers cheap ELISA-based (readily available), and accurate testing.

    Note - Cologuard only achieves 42% sensitivity for advanced adenomas.

    Rhythm is now on a mission to manufacture a new automated version of its test kit and then collect the required data regarding the reliability of the device itself. I believe the data will easily meet the IVDR requirements.

    Last edited by josiejow37: 09/03/24
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.002(3.23%)
Mkt cap ! $14.91M
Open High Low Value Volume
6.0¢ 6.0¢ 5.9¢ $9.212K 153.5K

Buyers (Bids)

No. Vol. Price($)
2 17675 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 76753 3
View Market Depth
Last trade - 15.49pm 01/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.